Prevalent low-frequency oscillation of heart rate is the strongest risk stratifier independent of all available mortality predictors in the placebo population of EMIAT trial
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2003）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要